Search alternatives:
marked decrease » marked increase (Expand Search)
latent decrease » latency decreased (Expand Search), largest decrease (Expand Search), content decreased (Expand Search)
large decrease » larger decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
b marked » _ marked (Expand Search), a marked (Expand Search), n marked (Expand Search)
a latent » _ latent (Expand Search), _ patent (Expand Search)
c large » _ large (Expand Search), a large (Expand Search), b large (Expand Search)
marked decrease » marked increase (Expand Search)
latent decrease » latency decreased (Expand Search), largest decrease (Expand Search), content decreased (Expand Search)
large decrease » larger decrease (Expand Search), large increases (Expand Search), large degree (Expand Search)
b marked » _ marked (Expand Search), a marked (Expand Search), n marked (Expand Search)
a latent » _ latent (Expand Search), _ patent (Expand Search)
c large » _ large (Expand Search), a large (Expand Search), b large (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Posterior distribution of the effect of the latent variable on the probability of seeking traditional remedies after a potential dog bite indicates a decreased likelihood of individuals seeking traditional remedies.
Published 2025“…<p>Posterior distribution of the effect of the latent variable on the probability of seeking traditional remedies after a potential dog bite indicates a decreased likelihood of individuals seeking traditional remedies.…”
-
12
-
13
-
14
Raw data of the charts in Fig 5.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
15
Antibodies used in western blot analysis.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
16
Raw data of the charts in Fig 3.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
17
Raw data of the charts in Fig 1.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
18
Raw data of the charts in Fig 6.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
19
Raw data of the charts in Fig 2.
Published 2024“…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
-
20